Article info
PDFOriginal research
Feasibility of intra-amniotic digoxin administration by obstetrics and gynecology trainees to induce fetal demise prior to medical abortion beyond 20 weeks
- Correspondence to Dr Tesfaye Hurissa Tufa, Obstetrics and Gynecology, Saint Paul's Hospital Millennium Medical College, Addis Ababa, Oromia, Ethiopia; tesfaye.hurisa{at}sphmmc.edu.et
Citation
Feasibility of intra-amniotic digoxin administration by obstetrics and gynecology trainees to induce fetal demise prior to medical abortion beyond 20 weeks
Publication history
- Received May 20, 2019
- Revised February 27, 2020
- Accepted March 11, 2020
- First published April 2, 2020.
Online issue publication
February 08, 2023
Article Versions
- Previous version (8 February 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© World Health Organization 2020. Licensee BMJ. This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (CC BY 3.0 IGO), which permits use, distribution,and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s original URL.Disclaimer: The author is a staff member of the World Health Organization. The author alone is responsible for the views expressed in this publication and they do not necessarily represent the views, decisions or policies of the World Health Organization.